摘要:
A class of tryptamine analogues bearing an optionally substituted phenyl nucleus at the 2-position are selective antagonists of the human 5-HT2A receptor and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of adverse neurological conditions, including psychotic disorders such as schizophrenia.
摘要:
A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of and/or prevention of Alzheimer's disease.
摘要:
A first aspect of the invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein: R1 is C3-8-cycloalkyl; X is O, NR7 or C3-6-heterocycloalkyl; R2 is aryl, heteroaryl, fused or unfused aryl-C3-6-heterocycloalkyl or fused or unfused heteroaryl-C3-6-heterocycloalkyl, each of which is optionally substituted by one or more substitutents selected from aryl, heteroaryl, C1-6-alkyl, C3-7-cycloalkyl and a group A, wherein said C1-6-alkyl group is optionally substituted by one or more substituents selected from aryl, heteroaryl, R10 and a group A, said heteroaryl group is optionally substituted by one or more R10 groups; and wherein said C3-6-heterocycloalkyl group optionally contains one or more groups selected from oxygen, sulfur, nitrogen and CO; R3 is C1-6-alkyl optionally substituted by one or more substituents selected from aryl, heteroaryl, —NR4R5, —OR6, —NR7(CO)R6, —NR7(CO)NR4R5, —NR7SO2R6, —NR7COOR7, —CONR4R5, C3-6-heterocycloalkyl and wherein R4-7 and A are as defined in the claims.Further aspects relate to the use of said compounds in the treatment of various therapeutic disorders, and more particularly as inhibitors of one or more kinases.
摘要翻译:本发明的第一方面涉及式(I)化合物或其药学上可接受的盐或酯,其中:R 1为C 3-8 - 环烷基; X是O,NR 7或C 3-6 - 杂环烷基; R 2是芳基,杂芳基,稠合或未稠合的芳基-C 3-6 - 杂环烷基或稠合或未稠合的杂芳基-C 3-6 - 杂环烷基,其各自任选被一个或多个选自芳基,杂芳基,C 1-6 - 烷基 C 3-7 - 环烷基和基团A,其中所述C 1-6 - 烷基任选被一个或多个选自芳基,杂芳基,R 10和A基团的取代基取代,所述杂芳基任选地被一个或多个R 10 团体 并且其中所述C 3-6杂环烷基任选地含有一个或多个选自氧,硫,氮和CO的基团; R 3是任选被一个或多个选自芳基,杂芳基,-NR 4 R 5,-OR 6,-NR 7(CO)R 6,-NR 7(CO)NR 4 R 5,-NR 7 SO 2 R 6,-NR 7 COOR 7,-CONR 4 R 5,C 3 -6-杂环烷基,其中R 4-7和A如权利要求中所定义。 其它方面涉及所述化合物在治疗各种治疗性疾病中的用途,更具体地涉及一种或多种激酶的抑制剂。
摘要:
A method and an apparatus are provided for inserting empty memory cells into a data flow of network connections of a computer network. In one example, the method includes receiving an insertion request for an empty memory cell to be inserted into the data flow. A base connection identification (CID) associated with the insertion request is also received. An appropriate insertion scheme for carrying out the insertion request is determined. Based on the appropriate insertion scheme, the insertion request is sent to an insertion device that is configured to insert the empty memory cell into the data flow. The memory cell is inserted prior to traffic shaping of the data flow.
摘要:
Tetrahydroindole derivatives of formula (I): are disclosed. These compounds modulate the activity of gamma-secretase and hence find use in treatment or prevention of Alzheimer's disease.
摘要:
Novel sulfamides of formula (I) are disclosed. The compounds exert an inhibitory action on the processing of APP by gamma-secretase, and are therefore useful in the treatment or prevention of Alzheimer's disease.
摘要:
Tetrahydroindole derivatives of formula (I): are disclosed. These compounds modulate the activity of gamma-secretase and hence find use in treatment or prevention of Alzheimer's disease.